You have 9 free searches left this month | for more free features.

Biguanides

Showing 26 - 50 of 76

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Glycemic Control wIth Vildagliptin and Metformin Combination

Withdrawn
  • Diabetes Mellitus, Type 2
  • (no location specified)
Oct 1, 2019

Diabetes, Type 2 Trial in Prague (Metformin Oral, Metformin local in AT, Exercise)

Completed
  • Diabetes Mellitus, Type 2
  • Metformin Oral
  • +2 more
  • Prague, Czechia
    Third Faculty of Medicine, Charles University
Feb 12, 2020

Practice Patterns of Type 2 Diabetes Mellitus Patients Treated

Completed
  • Diabetes Mellitus, Type 2
  • oral antidiabetic drugs
  • Shinagawa-ku, Japan
    Medical Data Vision Co. Ltd
Apr 12, 2019

Advanced LKB1-inactive Lung Adenocarcinoma Trial in Milan (Metformin Hydrochloride, Cisplatin, Carboplatin)

Recruiting
  • Advanced LKB1-inactive Lung Adenocarcinoma
  • Metformin Hydrochloride
  • +5 more
  • Milan, Italy
    Marina Chiara Garassino
Nov 12, 2020

PCOS Trial in Peshawar (Metformin (1000 mg daily), Pioglitazone (30 mg daily), Acetyl-L-carnitine (3 gm daily), Metformin,

Completed
  • PCOS
  • Metformin (1000 mg daily), Pioglitazone (30 mg daily), Acetyl-L-carnitine (3 gm daily)
  • Metformin, pioglitazone and placebo
  • Peshawar, Khyber Pukhtunkhwa, Pakistan
    Gynecology and Obstetric, Hayatabad Medical Complex
Jan 30, 2020

Surgical Site Infection Trial in Berlin-Steglitz (Polihexanide; Serasept, NaCl; saline)

Completed
  • Surgical Site Infection
  • Polihexanide; Serasept
  • NaCl; saline
  • Berlin-Steglitz, Berlin, Germany
    Charité Campus Benjamin Franklin
Aug 12, 2019

Surveillance Type 2 Diabetes Mellitus: Combination Therapy With

Completed
  • Surveillance
    • Tokyo, Japan
      (unnamed)
    Feb 27, 2017

    Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic

    Completed
    • Type 2 Diabetes Mellitus
    • Osaka, Japan
    • +1 more
    Oct 24, 2019

    COVID-19 Trial in Riyadh (combination product, radiation, drug)

    Not yet recruiting
    • COVID-19
    • Combination therapy plus Standard therapy
    • +2 more
    • Riyadh, Saudi Arabia
      Ministry of health.First health cluster ,Riaydh
    Sep 18, 2021

    Type 2 Diabetes Trial in Guangzhou (Complications assessment)

    Unknown status
    • Type 2 Diabetes Mellitus
    • Complications assessment
    • Guangzhou, Guangdong, China
      endocrinology department of the first affiliated hospital of Sun
    Apr 6, 2019

    Surveillance "Combined Use of Biguanides / Long-term Treatment"

    Completed
    • Type 2 Diabetes Mellitus
    • (no location specified)
    Sep 21, 2016

    Type 2 Diabetes Trial in Japan, Korea, Republic of, Taiwan (Insulin Peglispro, Insulin Glargine, Oral Antihyperglycemic

    Completed
    • Type 2 Diabetes Mellitus
    • Insulin Peglispro
    • +2 more
    • Aichi, Japan
    • +30 more
    Mar 13, 2019

    Type 2 Diabetes Trial in Seoul (alogliptin, Pioglitazone, alogliptin + pioglitazone)

    Completed
    • Type 2 Diabetes Mellitus
    • Seoul, Korea, Republic of
      Seoul St Mary's Hospital, The Catholic University of Korea
    Feb 7, 2019

    Diabetes, Physical Activity, Dietetic Rules Trial in France (SPA Treatment with therapeutic education and physical activity,

    Recruiting
    • Diabetes Mellitus
    • +3 more
    • SPA Treatment with therapeutic education and physical activity
    • Week end
    • Amiens, France
    • +8 more
    Jun 30, 2020

    NSCLC, Lung Adenocarcinoma Trial in Baltimore (Paclitaxel, Carboplatin, Bevacizumab)

    Terminated
    • Carcinoma, Non-Small-Cell Lung
    • Lung Adenocarcinoma
    • Baltimore, Maryland
    • +1 more
    Dec 16, 2018

    Beta Thalassemia Major Anemia Trial in Cairo. (Metformin)

    Unknown status
    • Beta Thalassemia Major Anemia
    • Cairo., Egypt
    • +1 more
    Jul 16, 2018

    Type 2 Diabetes Trial (Omarigliptin, Matching to omarigliptin)

    Completed
    • Type 2 Diabetes Mellitus
    • (no location specified)
    Aug 8, 2018

    Incretin-based Drugs and Acute Pancreatitis

    Completed
    • Diabetes Mellitus, Type 2
    • DPP-4 inhibitors
    • +7 more
    • Montreal, Quebec, Canada
      Lady Davis Institute for Medical Research, Jewish General Hospit
    Nov 1, 2016

    Brain Tumors Trial in Ramat Gan (radiation, drug, behavioral)

    Unknown status
    • Brain Neoplasms
    • Partial brain re-irradiation.
    • +2 more
    • Ramat Gan, Israel
      Sheba Medical Center
    Oct 26, 2017

    Diabetes, Type 2, Obesity Trial in Cleveland (Gastric bypass, Sleeve Gastrectomy)

    Completed
    • Diabetes Mellitus, Type 2
    • Obesity
    • Gastric bypass
    • Sleeve Gastrectomy
    • Cleveland, Ohio
      Cleveland Clinic
    Jul 18, 2017

    Spinal Cord Injuries, Insulin Resistance, Pre Diabetes Trial in West Orange (Exenatide 2 MG Injection [Bydureon], No

    Unknown status
    • Spinal Cord Injuries
    • +3 more
    • Exenatide 2 MG Injection [Bydureon]
    • No Intervention
    • West Orange, New Jersey
      Kessler Institute for Rehabilitation
    Sep 22, 2017

    Incretin-based Drugs and the Risk of Heart Failure

    Completed
    • Type 2 Diabetes Mellitus
    • DPP-4 inhibitors
    • +7 more
    • Montreal, Quebec, Canada
      Lady Davis Institute for Medical Research, Jewish General Hospit
    Apr 15, 2016

    Incretin-based Drugs and Pancreatic Cancer

    Completed
    • Diabetes Mellitus, Type 2
    • DPP-4 inhibitors
    • +6 more
    • Montreal, Quebec, Canada
      Lady Davis Institute for Medical Research, Jewish General Hospit
    Mar 11, 2016

    Coronary Disease, Cardiovascular Diseases, Heart Diseases Trial (Angioplasty, Transluminal, Percutaneous Coronary, other

    Completed
    • Coronary Disease
    • +5 more
    • Angioplasty, Transluminal, Percutaneous Coronary, other catheter-based interventions
    • +4 more
    • (no location specified)
    Jan 12, 2016

    Essential Hypertension Complicated by Type 2 Diabetes Trial in Kyoto-Shi (Azilsartan, Telmisartan)

    Completed
    • Essential Hypertension Complicated by Type 2 Diabetes Mellitus
    • Kyoto-Shi, Kyoto, Japan
      (unnamed)
    Apr 24, 2017